|
- Multimedia -
Safe Handling of Hazardous Drugs:
Practical Considerations for Compounding and Administration
 |
Program Description
Are you at risk for exposure to hazardous drugs?
Hazardous medications are capable of causing serious
effects in healthcare workers, including local
reactions, cancer, organ toxicity, fertility problems,
genetic damage, and birth defects. Regulations and
guidelines for handling hazardous drugs exist, but
exposures still happen. It is important to know how
contamination by hazardous drugs can occur and the most
effective methods to avoid it.
|
Learning Objectives
Upon completion of this activity, pharmacists and
nurses will be
able to:
-
Define hazardous drugs and negative health effects
associated with exposure.
-
Identify work practices that present a risk of exposure
to hazardous drugs.
-
Outline workplace strategies and practices to reduce
exposure and prevent contamination from hazardous drugs.
-
Describe technological advances that may reduce the
exposure of health care providers to hazardous drugs
during compounding and administration.
Program Faculty
Seth Eisenberg, RN, OCN®
Professional Practice Coordinator, Infusion Services
Seattle Cancer Care Alliance
Seattle, WA
Full Bio and
Disclosure
Luci A. Power, MS, RPh
Senior Pharmacy Consultant
Power Enterprises
San Francisco, CA
Full Bio and
Disclosure
CE Accreditation:
Pharmacists:
ProCE,
Inc is accredited by the Accreditation Council for Pharmacy
Education as a provider of continuing pharmacy education.
ACPE Universal Activity Number 221-000-09-091-H05-P has been
assigned to this knowledge-based home-study activity
(initial release date 12-21-09). This activity is acceptable
for 1.0 contact hour (0.10 CEU) in states that recognize
ACPE providers. It is provided at no cost to participants.
Statements of credit will be issued online at www.ProCE.com
upon successful completion of the post-test (≥70% correct).
No partial credit will be given.
Expiration Date: 12-21-2012
Nurses:
Nurse CE is provided for this home-study activity
through collaboration between ProCE, Inc. and Wild Iris
Medical Education, Inc. (WSNA CEARP Provider number
PA-5/Feb/11). Wild Iris Medical Education is an approved
provider of continuing education by the Washington State
Nurses Association, an accredited approver by the American
Nurses' Credentialing Center's Commission on Accreditation
(California Board of Registered Nursing Provider #12300).
This activity provides 1.0 contact hour of nurse CE credit.
Expiration Date: 12-21-2012
Funding
This program was supported by an
educational grant from ICU Medical, Inc.

|
|
To
Participate
|
|
To participate in this Web-based continuing
education activity: |
|
1. |
Review the program description and objectives. |
| 2. |
View the program by clicking on
the link below. |
| 3. |
Take the online post-test and
complete the evaluation by clicking the post-test hyperlink on the final
slide of the program (registration will be required). |
|
|
View this Program
|
|
|
|
Post Test & Evaluation |
|
Take Post-Test
NOTE: If you attended the webinar titled
"Safe Handling of Hazardous Drugs: Practical Considerations for Compounding
and Administration" that was held on June 4, August 26, September 24, and
November 16, 2009 AND received CE credit (i.e. a pharmacist CE statement of
credit or a nurse CE certificate), you are NOT
allowed to receive credit again for this home-study web course. |
|
|
|
The material presented here does
not reflect the views of Pharmacy Choice, Inc., ProCE, Inc.,
RxSchool, ICU Medical, Inc. or the companies providing educational content.
These materials may discuss uses and dosages for therapeutic
products, processes, procedures and inferred diagnoses that
have not been approved by the United States Food and Drug
Administration. A qualified health care professional should
be consulted before using any therapeutic product discussed.
All readers and continuing education participants should
verify all information and data before treating patients or
employing any therapies described in this continuing
education activity. |